Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6160)
All Articles published online
|
Publishing Process of This Article
|
Nov 27, 2021 (publication date) through May 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ma Y, Nenkov M, Chen Y, Press AT, Kaemmerer E, Gassler N. Fatty acid metabolism and acyl-CoA synthetases in the liver-gut axis. World J Hepatol 2021; 13(11): 1512-1533 [PMID: 34904027 DOI: 10.4254/wjh.v13.i11.1512] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v13/i11/1512.htm |
| Number | Citing Articles |
| 1 |
Kai Liang, Jian-Ye Dai. Progress of potential drugs targeted in lipid metabolism research. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1067652
|
| 2 |
Linlin Zhang, Xiangdong Wang. Characteristics of long‐chain acyl‐CoA synthetases in metabolism and cancer. Clinical and Translational Discovery 2023; 3(3) doi: 10.1002/ctd2.200
|
| 3 |
Keyu Xiang, Zhiyu He, Jianxin Fu, Guoqing Wang, Hongyan Li, Yu Zhang, Shicui Zhang, Lingxin Chen. Microplastics exposure as an emerging threat to ancient lineage: A contaminant of concern for abnormal bending of amphioxus via neurotoxicity. Journal of Hazardous Materials 2022; 438: 129454 doi: 10.1016/j.jhazmat.2022.129454
|
| 4 |
Shucheng Huang, Luxi Lin, Shiqiong Wang, Wenli Ding, Chaodong Zhang, Aftab Shaukat, Bowen Xu, Ke Yue, Cai Zhang, Fang Liu. Total Flavonoids of Rhizoma Drynariae Mitigates Aflatoxin B1-Induced Liver Toxicity in Chickens via Microbiota-Gut-Liver Axis Interaction Mechanisms. Antioxidants 2023; 12(4): 819 doi: 10.3390/antiox12040819
|
| 5 |
Lukas Krähenbühl, Stephan Krähenbühl. Rats with Long-Term Cholestasis Have a Decreased Cytosolic but Maintained Mitochondrial Hepatic CoA Pool. International Journal of Molecular Sciences 2023; 24(5): 4365 doi: 10.3390/ijms24054365
|
| 6 |
Yuanfeng Zou, Hong Yan, Cenyu Li, Fang Wen, Xiaoping Jize, Chaowen Zhang, Siqi Liu, Yuzhe Zhao, Yuping Fu, Lixia Li, Fan Liu, Ji Chen, Rui Li, Xingfu Chen, Mengliang Tian. A Pectic Polysaccharide from Codonopsis pilosula Alleviates Inflammatory Response and Oxidative Stress of Aging Mice via Modulating Intestinal Microbiota-Related Gut–Liver Axis. Antioxidants 2023; 12(9): 1781 doi: 10.3390/antiox12091781
|
| 7 |
Sylwia Szrok-Jurga, Aleksandra Czumaj, Jacek Turyn, Areta Hebanowska, Julian Swierczynski, Tomasz Sledzinski, Ewa Stelmanska. The Physiological and Pathological Role of Acyl-CoA Oxidation. International Journal of Molecular Sciences 2023; 24(19): 14857 doi: 10.3390/ijms241914857
|
| 8 |
Wei Song, Ruixue Wen, Tianqi Liu, Lanqi Zhou, Guoze Wang, Xiaoshuang Dai, Lin Shi. Oat-based postbiotics ameliorate high-sucrose induced liver injury and colitis susceptibility by modulating fatty acids metabolism and gut microbiota. The Journal of Nutritional Biochemistry 2024; 125: 109553 doi: 10.1016/j.jnutbio.2023.109553
|
| 9 |
Hojatullah Maleki, Mahnaz Omidi, Mohamadreza Yousefi. Effect of High-Intensity Interval Training on the Levels of Liver Fat Transporter Proteins (LFAB and CD36) in Rats with Fatty Liver. Jundishapur Journal of Health Sciences 2024; 16(1) doi: 10.5812/jjhs-139909
|
| 10 |
Yumeng Zhao, Xiaojie Zhang, Min An, Juntao Zhang, Yanhua Liu. Recent advancements in nanomedicine based lipid metabolism for tumour immunotherapy. Journal of Drug Targeting 2023; 31(10): 1050 doi: 10.1080/1061186X.2023.2283829
|
| 11 |
Yunxia Ma, Miljana Nenkov, Alexander Berndt, Mohamed Abubrig, Martin Schmidt, Tim Sandhaus, Otmar Huber, Joachim H. Clement, Susanne M. Lang, Yuan Chen, Nikolaus Gaßler. The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer. Cancers 2024; 16(6): 1170 doi: 10.3390/cancers16061170
|